-
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis Nat. Rev. Nephrol. (IF 28.6) Pub Date : 2025-06-04
Ellen F. CarneyUraemic calciphylaxis is a rare disease characterized by subcutaneous vessel thrombosis and ulcerative skin necrosis that predominantly affects patients with kidney failure. The disease results in substantial morbidity and mortality, but the pathogenesis is unclear and no curative therapies are available. Now, a new study reports a pathogenic role of IL-6–tissue factor (TF) signalling in uraemic calciphylaxis
-
Engineered CAR macrophages target kidney inflammation Nat. Rev. Nephrol. (IF 28.6) Pub Date : 2025-05-27
Susan J. AllisonThe administration of anti-inflammatory macrophages has been proposed as an approach to reduce tissue injury in response to inflammation; however, this approach is limited by the instability of macrophages and their potential to switch to a pro-inflammatory phenotype. To overcome these limitations, researchers have now developed a chimeric antigen receptor (CAR) macrophage (CAR-M) that demonstrates
-
Questions and Caveats in Antigen-Defined Membranous Nephropathy. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-27
Nicole K Andeen,Vanderlene L Kung,Rupali S Avasare,Sean Barbour,Megan Griffith,Mei Lin Z Bissonnette,Candice RoufosseRemarkable progress has been made in the discovery of autoantigens in membranous nephropathy. With increasing testing for membranous antigens in daily practice, it is important to consider the varying strength of association between certain antigens and underlying conditions. This review explores questions and caveats which arise when assessing results of membranous antigen testing. Specifically, we
-
The national landscape of kidney transplantation for undocumented immigrants: advancing kidney transplantation equity. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Katherine Rizzolo,Leonela Villegas,Lilia CervantesAlthough undocumented people are eligible for kidney transplant from a regulatory standpoint, undocumented individuals are often excluded from federal health insurance, leading to difficulty accessing kidney transplant. Menon et al. highlight lower mortality and graft failure rates for presumed undocumented immigrants compared with residents and citizens post-transplant. In this commentary, we emphasize
-
Osteocytes burn out, give bone a break. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Aline MartinThe pathogenic mechanisms of chronic kidney disease-induced osteoporosis are not well understood and might involve metabolic alterations and apoptosis of osteocytes. In this issue, Hsu et al. present experimental work in uremic mice and cultured mouse osteoblasts showing that impaired mitochondrial function and mitophagy in osteocytes contribute to chronic kidney disease-associated osteoporosis. They
-
Executive summary for the China Kidney Disease Network (CK-NET) 2017-2018 Annual Data Report. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Chao Yang,Bixia Gao,Fang Wang,Hong Chu,Jinwei Wang,Xiaoyu Sun,Ping Zhang,Hui Xu,Huijuan Mao,Changying Xing,Menghua Chen,Li Zuo,Yue Wang,Feng Yu,Hong Zhang,Haibo Wang,Jianghua Chen,Luxia Zhang,Ming-Hui Zhao,Chronic kidney disease (CKD) has become a public health issue. Rapid urbanization in China has been intimately linked to shifts in the spectrum of CKD, particularly as regards CKD related to diabetes mellitus. By amalgamating diverse data streams and harnessing cutting-edge technologies, the China Kidney Disease Network aspires to evolve into a comprehensive surveillance framework for kidney diseases
-
SGLT2 inhibitors fulfill their expectations in diabetic kidney transplant recipients. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Elisabet Van Loon,Pieter Gillard,Maarten Naesens -
Medical care of acute kidney injury in limited resource settings: a call to action. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Yasser M Abdelhamid,Amel Harzallah,Vincent Boima,Bala Waziri,Niakhaleen Keita, -
Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
David M Charytan,Wolfgang C Winkelmayer,Christopher B Granger,John P Middleton,Charles A Herzog,Glenn M Chertow,James M Eudicone,Jeremy D Whitson,James A Tumlin, -
The Standardized Outcomes in Nephrology (SONG) initiative: a decade of harmonizing patient voices and research in kidney disease. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Colm O'Reilly,Jonathan C Craig,Younghee Cho,Sally Crowe,John S Gill,Brenda Hemmelgarn,Martin Howell,Anastasia Hughes,Angela Ju,Karine Manera,Braden Manns,Roberto Pecoits-Filho,Benedicte Sautenet,Nicole Scholes-Robertson,Armando Teixeira-Pinto,Peter Tugwell,Wim Van Biesen,Andrea K Viecelli,Angela Yee-Moon Wang,Wolfgang C Winkelmayer,Germaine Wong,Chandana Guha,Allison Jaure -
Effective management of chyluria with retrograde thoracic duct catheterization and embolization. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Matthias Barral,Lionel Arrivé,Armance Marchal,Raphael Dautry -
"Conclusions from a KDIGO Controversies Conference" and CKD-MBD-associated osteoporosis. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Michael Pazianas,Paul D Miller -
The Case | A 67-year-old woman with peripheral neuropathy and nephrotic syndrome. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Charankumar Swamikannu,Mookiah Seenivasan,Jayalakshmi Seshadri,Anila Abraham Kurien -
Osmotic nephropathy induced by SGLT2 inhibitor overdose. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Yoshihiro Kawata,Makoto Araki,Yasuhiro Onodera,Yayoi Ogawa,Mitsuru Yanai -
Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Espen Nordheim,Markus Hovd,Dag Olav Dahle -
Expanding the perspective: addressing additional limitations in cardiovascular risk assessment of immunosuppressive therapies. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Mian Wei,Yun Liu,Jianhua Zhu -
How frequent is frequent? Rethinking monitoring intervals in glomerular disease. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Mohamed E Elrggal -
Heartfelt concerns: the overlooked cardiac risks in glomerular disease management. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Jiachuan Xiong,Jinghong Zhao -
Chronic kidney disease and dementia: an epidemiological perspective Nat. Rev. Nephrol. (IF 28.6) Pub Date : 2025-05-22
M. Arfan Ikram -
A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients. Kidney Int. (IF 14.8) Pub Date : 2025-05-22
William R Mulley,Dhakshayini Tharmaraj,Kevan R Polkinghorne,Greg H Tesch,Sukhpal K Dayan,Edward Kwan,Moshe Olshansky,Tia Mark,Darren Lee,Peter F Mount,Germaine Wong,Kate R Wyburn,Wai H Lim,Peter G Kerr,David J Nikolic-Paterson,John KanellisINTRODUCTION Chronic active antibody-mediated rejection (AMR) is the leading cause of death-censored kidney allograft loss, with no proven treatments. While intravenous immunoglobulin (IVIG) has been used in certain cases, its efficacy is unknown. METHODS In this open-label multicenter randomized controlled trial (VIPAR), participants with biopsy-proven chronic active AMR, were assigned to six doses
-
mTOR Inhibitors and Vaccine Response in Kidney Transplant Recipients. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-22
Griffith B Perkins,Matthew J Tunbridge,Cheng Sheng Chai,Christopher M Hope,Arthur Eng Lip Yeow,Tania Salehi,Julian Singer,Bree Shi,Makutiro G Masavuli,Zelalem Addis Mekonnen,Pablo Garcia-Valtanen,Svjetlana Kireta,Julie K Johnston,Christopher J Drogemuller,Beatrice Z Sim,Shane M Spencer,Benedetta C Sallustio,Iain Comerford,George Bouras,Daniela Weiskopf,Alessandro Sette,Anupriya Aggarwal,Vanessa MilogiannakisBACKGROUND Failure to develop protective immunity in response to vaccination is common among kidney transplant recipients, rendering them susceptible to severe infection. Novel strategies are required. Here, we investigated the potential of mechanistic-target-of-rapamycin (mTOR) inhibitors to improve vaccine responses. METHODS Humoral and cellular responses to primary COVID-19 vaccination (ChAdOx1
-
Restoration of branched chain amino acid catabolism improves kidney function in preclinical cardiovascular-kidney-metabolic syndrome models. Kidney Int. (IF 14.8) Pub Date : 2025-05-21
Eliza Bollinger,George Williams,Mary E Piper,Kimberly Steen,Kelly Tam Neale,Xian Chen,Mackenzie Marshall,Srinath Jagarlapudi,Yasaman Jami-Alahmadi,Pierre M Jean-Beltran,LouJin Song,Joshua Chiou,Frank Geoly,Sarah R Vargas,Ying Zhang,Elaine Kuang,Daniel Callahan,John C Stansfield,Max Russo,John Griffin,Zhongyuan Sun,Melissa R Miller,Craig L Hyde,Michelle F Clasquin,Katherine Hales,Natalie A Daurio,JustinINTRODUCTION Patients with metabolic syndrome and heart failure (HF) often have accompanying kidney dysfunction, which was recently defined as cardiovascular-kidney-metabolic (CKM) syndrome. Prior metabolomics profiling of metabolic syndrome patients identified a plasma branched chain amino acid (BCAA) signature, and BCAAs themselves are elevated in the myocardium of patients with HF, potentially due
-
Clinical relevance of computationally derived tubular features and their spatial relationships with the interstitial microenvironment in minimal change disease/focal segmental glomerulosclerosis. Kidney Int. (IF 14.8) Pub Date : 2025-05-21
Fan Fan,Qian Liu,Jarcy Zee,Takaya Ozeki,Dawit Demeke,Yingbao Yang,Markus Bitzer,Christopher L O'Connor,Alton B Farris,Bangcheng Wang,Manav Shah,Jackson Jacobs,Laura Mariani,Kyle Lafata,Jeremy Rubin,Yijiang Chen,Lawrence Holzman,Jeffrey B Hodgin,Anant Madabhushi,Laura Barisoni,Andrew JanowczykBACKGROUND Visual scoring of tubular damage has limitations in capturing the full spectrum of structural changes and prognostic potential. Here, we investigated if computationally quantified tubular features can enhance prognostication and reveal spatial relationships with interstitial fibrosis. METHODS Deep-learning and image-analysis approaches were employed on 254/266 Periodic acid Schiff-stained
-
Authors' Reply: Expanding the Implications of Proximal Tubular Function Assessment. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-21
Bernardo Rodriguez-Iturbe,Ana Karen Fernández-Yepez,Magdalena Madero -
mTORc1 in Distal Convoluted Tubule (DCT) and Renal Potassium (K+) Handling. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-21
Yu Xiao,Xin-Peng Duan,Cheng-Biao Zhang,Wen-Hui Wang,Dao-Hong LinBACKGROUND Mechanistic-target-of-rapamycin-complex-1 (mTORc1) plays a role in maintaining K + homeostasis. We now examine whether mTORc1 of distal-convoluted-tubule (DCT) regulates Kir4.1/Kir5.1 channels and thiazide-sensitive-Na-Cl cotransporter, which plays a role in regulating renal K + excretion. METHODS We used patch-clamp-technique to examine basolateral Kir4.1/Kir5.1 in early-DCT, immunoblotting
-
Expanding the Implications of Proximal Tubular Function Assessment. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-21
Chia-Ter Chao -
Voclosporin Overdose-Induced Peroxisomal Structural Changes and AKI Are Prevented by Renal Indole Detoxifier, INMT. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-21
Kazuhiro Hasegawa,Yusuke Sakamaki,Masanori Tamaki,Shu WakinoBACKGROUND The novel calcineurin inhibitor (CNI) voclosporin is effective in treating lupus nephritis but has been associated with acute kidney injury (AKI) through largely unknown mechanisms. Voclosporin-induced AKI revealed that voclosporin reduces the expression of indolethylamine N-methyltransferase (Inmt), an enzyme responsible for detoxifying local uremic toxins such as indole. This study investigates
-
Sex Inequities in Kidney Transplantation: A Persistent and Multifaceted Challenge. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-21
Priti Meena,Silvi Shah -
Frailty in Adults with Chronic Kidney Disease and Validation of the Kidney Failure Risk Equation in Frailty Sub-Groups Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-21
Heather Walker, Juan-Jesus Carrero, Michael K. Sullivan, Ryan Field, Jennifer S. Lees, Peter Hanlon, Anne-Laure Faucon, Edouard L. Fu, Giorgi Beridze, Bhautesh Dinesh Jani, Katie Gallacher, Patrick B. Markaim was to validate KFRE by frailty status and assess whether model performance could be improved by using cystatin based estimated glomerular filtration rate (eGFR) equations and to assess the impact of accounting for competing mortality risk. Methods: We studied adults from the prospective research cohort UK Biobank with CKD G3-5 (eGFR <60mL/min/1.73m2) by any of the three CKD-EPI consortium eGFR
-
The Florence Working Group: An Initiative for a Collaborative Effort to Improve the Classification and Scoring Systems in ANCA-Glomerulonephritis Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-21
Silke R Brix, Annelies Berden, Giacomo Emmi, Lauren Floyd, J. Charles Jennette, Andreas Kronbichler, Irmgard Neumann, Martina Uzzo, Augusto Vaglio, Maria Wester Trejo, Thorsten Wiech, David Jayne, Ingeborg BajemaAn abstract is unavailable. This article is available as a PDF only.
-
The Kidney Disease Screening and Awareness Program (KDSAP): Transforming Community Outreach and Inspiring Interest in Nephrology Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-21
Kavya M. Shah, Jacqueline Lee, Benjamin J. Lee, Ming-Yan Jiang, Li-Li HsiaoAn abstract is unavailable. This article is available as a PDF only.
-
A Home Hemodialysis Objective Structured Clinical Examination (OSCE) for Formative Assessment of Nephrology Fellows Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-21
Jason A. Jones, Trevor W. Tobin, Maria C. Bermudez, Gregory L. Braden, Evan Fisher, Nupur Gupta, Daniel Landry, Christopher LeBrun, Robert Nee, Bret Pasiuk, Christina M. Yuanily validated a formative objective structured clinical examination (OSCE) assessing clinical care of an uncomplicated patient initiating HHD, using a unified model of construct validity. Methods: The OSCE was developed by a nephrology fellow and five faculty (three practicing HHD). The nine-member test committee (five in HHD practice; one HHD care partner) assessed test item difficulty/relevance and
-
Progress Toward a Better Predictor of Remission in Anti-Phospholipase A2 Receptor-Associated Membranous Nephropathy Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-15
Patrick H. NachmanAn abstract is unavailable.
-
Sodium-Glucose Cotransporter-2 Inhibitor Therapy and Longitudinal Changes in Kidney Function among Veterans with Autosomal Dominant Polycystic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-16
Meghana Eswarappa, Erin Madden, Michael G. Shlipak, Xiangqin Cui, Michal Mrug, Michelle M. Estrella, Meyeon Parkstudy within the Veterans Health Administration included adults with an ADPKD diagnosis code who initiated SGLT2i between January 2017 and May 2023. Repeated measures models were used to evaluate eGFR slope before and after SGLT2i initiation. Among patients with ADPKD and type 2 diabetes mellitus (T2DM), a target trial emulation was used to compare the effects of SGLT2i versus dipeptidyl peptidase-4
-
The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy. Kidney Int. (IF 14.8) Pub Date : 2025-05-20
Nattawat Klomjit,Michael D Evans,Maria Vargas,Nicholas Marka,Fernando Fervenza,Sanjeev Sethi,Ladan ZandINTRODUCTION Monoclonal gammopathy of renal significance (MGRS) is increasingly recognized as an important causes of kidney failure. A kidney biopsy remains an important diagnostic measure. However, a kidney biopsy is not without risks. Here, we devised the Mayo MGRS Prediction Tool to assess the probability of finding MGRS in patients with chronic kidney disease with monoclonal gammopathy (MG). METHODS
-
From Niche to Norm: A Multi-Action Plan to Close Gaps and Mainstream Incremental Hemodialysis. Kidney Int. (IF 14.8) Pub Date : 2025-05-20
Mariana Murea,Massimo Torreggiani,Javier Deira,Tammy L Sirich,Andrea K Viecelli,Enric Vilar,Miguel Á Suárez-Santisteban,John T Daugirdas,Ken Farrington,Kamyar Kalantar-Zadeh,Patrick Saudan,David A Jaques,Kristie L Foley,Ucheoma C Nwaozuru,Andrew Davenport,Elizabeth J Lindley,James Tattersall,Carlo Basile,Francesco G Casino,Giorgina B PiccoliAttention is increasingly turning toward the individualization of hemodialysis prescriptions through an incremental start. This approach prioritizes patient's clinical needs over rigid metrics like dialysis urea depuration, begins with fewer sessions (one or two per week), and gradually increases in frequency and/or duration based on patient's evolving clinical condition. Clinical manifestations related
-
The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of TET2/NLRP3 inflammasome signaling pathway. Kidney Int. (IF 14.8) Pub Date : 2025-05-16
Mingwei Fu,Zirong Lan,Yuanzhi Ye,Yuan Gong,Qingchun Liang,Mingxi Li,Liyun Feng,An Chen,Qianqian Dong,Yining Li,Siyi Wang,Xiaoyu Liu,Xiuli Zhang,Jing-Song Ou,Lihe Lu,Jianyun YanINTRODUCTION Vascular calcification is prevalent in chronic kidney disease (CKD), but existing medical treatments fail to achieve satisfactory therapeutic effects. Vascular calcification is now recognized as an active multifactorial process involving diverse mechanisms. Alpha-ketoglutarate (AKG), an intermediate in tricarboxylic acid cycle, has been demonstrated to extend lifespan and ameliorate age-related
-
Expanding the spectrum of genetic causes of DNA-specific exonucleaseTREX1 variants in thrombotic microangiopathy Kidney Int. (IF 14.8) Pub Date : 2025-05-16
Zhuo-ran Song, Zhi-ying Liu, Meng-shi Li, Yang Li, Jing-yi Li, Ji-Cheng Lv, Hong Zhang, Xu-jie ZhouThrombotic microangiopathy (TMA) is a complex condition involving endothelial damage and microvascular thrombi. The International Society of Nephrology’s HUS International Forum identified genetic variants as crucial for tailored therapies like plasma exchange and anti-complement therapy. Recent studies suggested that new pathogenic genes beyond complement, and coagulation pathways contribute to TMA
-
A nationwide register-based cohort study examined the association between preeclampsia in mothers and the risk of kidney disease in their offspring. Kidney Int. (IF 14.8) Pub Date : 2025-05-16
Ida Lihme,Saima Basit,Frederikke Lihme,Mette B Damholt,Sarah Hjorth,Ellen A Nohr,Heather A BoydINTRODUCTION Women with preeclampsia often deliver preterm (under37 weeks gestation). Preterm birth is associated with an increased risk of offspring kidney disease, but whether preeclampsia is independently associated with kidney disease risk is unknown. Here, we conducted a register-based cohort study to explore associations between maternal preeclampsia and offspring kidney disease after accounting
-
Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis. Kidney Int. (IF 14.8) Pub Date : 2025-05-16
Sandra Habbig,Hanna Debiec,Malha Chedik,Dirk L Stippel,Florian Erger,Alexia Lourenço,Max C Liebau,Pierre RoncoINTRODUCTION Disease recurrence after kidney transplantation (KTx) remains a major challenge in patients with primary focal segmental glomerulosclerosis (pFSGS). Antibodies targeting the slit diaphragm protein nephrin have been identified in patients with early disease recurrence. Here, we describe monitoring and effective pre-transplant elimination of anti-nephrin antibodies in an adolescent with
-
Understanding Rare Kidney Stone Diseases: A Review. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-16
Michelle A Baum,Mallory Mandel,Michael Jg SomersRare kidney stone diseases typically present with nephrolithiasis or nephrocalcinosis in childhood or adolescence. Affected individuals might face kidney injury and even kidney failure related to associated complications. Screening blood and urine tests recommended for patients with nephrolithiasis/nephrocalcinosis help guide further evaluation, and the increased availability and decreased costs of
-
Kidney Dysfunction in Heart Failure: Core Curriculum 2025. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-16
Kevin Bryan Lo,Arun Janakiraman,Janani RangaswamiThe pathophysiology of heart failure (HF) with kidney dysfunction is represented by several maladaptive bidirectional pathways wherein acute or chronic dysfunction of one organ drives acute or chronic dysfunction in the other organ. Suboptimal decongestion, diuretic resistance, and low use rates of guideline-directed medical therapy in individuals with kidney dysfunction and HF contribute to poor cardiovascular
-
Adapting to Artificial Intelligence in Nephrology Practice. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-16
Chia-Ter Chao -
Finitude and Transcendence: A Perspective on Treatment Burden From the Perspective of a Doctoral Researcher and a Former Patient on Peritoneal Dialysis. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-16
Kitty Sze Wing Ko -
CKD, Cardiovascular Risk Estimation, and Gaps in Therapy: A Shift to PREVENT. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-16
Tyrone G Harrison,Matthew T James -
Hypercalcemia's Hidden Regulator: Calcium-Sensing Receptor and the Kidney's Secret Weapon J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-15
Jessica Paola Bahena-López, Gerardo GambaAn abstract is unavailable.
-
Long-Term Exposure to Uranium and Arsenic in Community Drinking Water and CKD Risk Among California Women. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-15
Danielle N Medgyesi,Sumit Mohan,Komal Bangia,Emma S Spielfogel,Maya Spaur,Anirban Basu,Jared A Fisher,Jessica M Madrigal,Arce Domingo-Relloso,Rena R Jones,Mary H Ward,James V Lacey,Tiffany R Sanchez,RATIONALE & OBJECTIVE Metals/metalloids in drinking water, including uranium and arsenic, may damage kidney function and increase chronic kidney disease (CKD) risk. We evaluated exposure to these contaminants in community water supplies (CWS) and CKD risk in the California Teachers Study. STUDY DESIGN Prospective cohort study. SETTING & PARTICIPANTS 88,185 women who were California teachers and school
-
Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-15
Chenxi Gao,Yunwen Xu,Sneha Mehta,Yingying Sang,Carina Flaherty,Aditya Surapaneni,Krutika Pandit,Alexander R Chang,Jamie Alton Green,Morgan E Grams,Jung-Im ShinRATIONALE & OBJECTIVES Accurate ascertainment of end-stage kidney disease (ESKD) in electronic health records (EHRs) data is important for much epidemiological research. This study aimed to develop and validate an algorithm using diagnosis and procedure codes to identify patients with ESKD (treated with maintenance dialysis or kidney transplantation) in EHRs data. STUDY DESIGN Study of diagnostic algorithms
-
Inflammatory and Cardiovascular Events in CKD: The Multi-Ethnic Study of Atherosclerosis. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-15
Gautam R Shroff,Daniel A Duprez,Evan Manning,Yuni Choi,Holly J Kramer,Alexander R Chang,David R JacobsRATIONALE & OBJECTIVE Chronic kidney disease (CKD) is associated with a proinflammatory state caused by maladaptive immune response, predisposing to cardiovascular (CVD) and inflammatory/infectious disease outcomes. We sought to examine the association of chronic inflammation-related disease (ChrIRD) as compared to CVD events with worsening kidney function. STUDY DESIGN Longitudinal, observational
-
Metabolic dysfunction–associated kidney disease: pathogenesis and clinical manifestations Kidney Int. (IF 14.8) Pub Date : 2025-05-14
Anip Bansal, Michel ChoncholIn recent years, there have been significant changes in the lifestyle and dietary habits of the population characterized by an increased intake of high-calorie food and a sedentary lifestyle without physical activity. The increased prevalence of overweight and obesity has led to metabolic dysfunction and related complications, such as cardiovascular disease and chronic kidney disease. The purpose of
-
Video-Assisted Electronic Consent versus Standard Consent for Percutaneous Kidney Biopsy Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-14
Thelma BarberAn abstract is unavailable.
-
Evidence-Based Guidance for Strategies for Blood Transfusion with CKD and Myocardial Infarction J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-13
Michelle M.Y. Wong, Charles A. HerzogAn abstract is unavailable.
-
Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-13
Glenn M Chertow,Kai-Uwe Eckardt,Mark J Sarnak,Wolfgang C Winkelmayer,Rajiv Agarwal,Todd Minga,Wenli Luo,Steven K BurkeBACKGROUND Vadadustat's global clinical program was comprised of four noninferiority trials comparing vadadustat and darbepoetin alfa for CKD-related anemia: two in dialysis-dependent (DD)-CKD and two in non-dialysis-dependent (NDD)-CKD. While vadadustat met prespecified noninferiority criteria for hematological efficacy globally, it did not meet noninferiority criteria for cardiovascular safety in
-
How I Approach Hematuria and Proteinuria: Can We Prevent the Same Mistake from Happening Twice? Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-13
Timothy T. YauAn abstract is unavailable. This article is available as a PDF only.
-
Effects of Lowering Dietary Phosphorus Additive Intake on Mineral Metabolism in Adults with and without Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2025-05-13
Muhammad Bilal Khan, Mercedes R. Carnethon, Tamara Isakova, Myles Wolf, Orlando M. Gutiérrezfeeding study in 39 adults without and 11 adults with CKD. Participants were fed a phosphorus additive-enhanced diet for two weeks followed by a low additive diet for six weeks. Both diets were identical except for phosphorus additive content. Blood and urine samples were collected at regular intervals with analyses comparing follow-up measures of mineral metabolism markers to baseline values. Results:
-
Authors' Reply: Acetazolamide and Renal Hemodynamics: Interplay between Tubuloglomerular Feedback and Renin-Angiotensin-Aldosterone System Adaptation. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-12
Charles Ginsberg,Jeremy Pettus,Joachim H Ix -
Fenofibrate-Induced Osmotic Nephropathy: A Novel Mechanism of Acute Kidney Injury. Am. J. Kidney Dis. (IF 9.4) Pub Date : 2025-05-12
Raymond Lin,Seethalakshmi Viswanathan,Nikki L WongFibrates are a commonly utilized medication in the management of dyslipidaemia and cardiovascular risk. These agents have a well-documented association with reversible elevations in serum creatinine and in some instances acute kidney injury. The mechanism underlying the renal effects of fibrates are currently not well-understood. We describe a case of acute kidney injury in a patient who was administered
-
The intelligent podocyte: sensing and responding to a complex microenvironment Nat. Rev. Nephrol. (IF 28.6) Pub Date : 2025-05-08
John F. Bertram, Luise A. Cullen-McEwen, Vinicius Andrade-Oliveira, Niels Olsen Saraiva Câmara -
Authors' Reply: Concerns about Hospitalization on Cystatin C- and Creatinine-Based eGFR. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-08
Ian E McCoy,Chi-Yuan Hsu -
Engineered Neuromedin U Promotes Type 2 Innate Immunity and Renoprotection in Acute Kidney Injury. J. Am. Soc. Nephrol. (IF 10.3) Pub Date : 2025-05-08
Sara Trindade-Correia,Vasco Correia,Filipe Delgado,Marta Baptista,Inês Amendoeira Cabral,Tânia Carvalho,Luana Macedo,Margarida Nunes,Pedro Z Andrade,Filipa Cardoso,Julie Chesné,David F Braga Malta,Covadonga Pañeda,Henrique Veiga-Fernandes,Vânia CardosoBACKGROUND Acute kidney injury (AKI) is a severe condition leading to the sudden loss of kidney function. Activation of type 2 innate lymphoid cells (ILC2s) by neuromedin U (NMU) is highly selective and key in controlling mucosal tissue repair and homeostasis. Renal ILC2s are associated with renoprotective effects in AKI. Here, we explored the therapeutic potential of an engineered NMU analogue (LIMM102)